Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marina Vivarelli

Showing results (1-10 of 141) with videos related to

Pageof 15
Sort By:
Kidney International|July 23, 2022
What to do when a child with nephrotic syndrome has a cold? Learning from RCTsMarina Vivarelli, Elisabeth Hodson
Journal of Clinical Medicine|June 26, 2025
Advances in Complement Inhibitory Strategies for the Treatment of Glomerular Disease: A Rapidly Evolving FieldEster Conversano, Marina Vivarelli
Kidney International|November 25, 2019
A new mouse model of anti-GBM disease sheds light on maternal transfer of alloantibodies in glomerular diseaseMarina Vivarelli, Francesco Emma
Kidney International|January 5, 2019
Levamisole for children with nephrotic syndrome: new evidence for the use of an "old" drugMarina Vivarelli, Francesco Emma
Clinical Journal of the American Society of Nephrology : CJASN|November 7, 2022
How I Treat Steroid-Sensitive Nephrotic Syndrome in ChildrenMarina Vivarelli, Francesco Emma
Kidney International|July 1, 2025
Rituximab as first-line steroid-sparing agent in pediatric nephrotic syndrome: too early?Marina Vivarelli, Manuela Colucci
Seminars in Thrombosis and Hemostasis|May 7, 2014
Treatment of C3 glomerulopathy with complement blockersMarina Vivarelli, Francesco Emma
Kidney International|February 22, 2024
Anti-nephrin antibodies in recurrence of focal segmental glomerulosclerosis: closer to discovering the Holy Grail?Marina Vivarelli, Manuela Colucci
Kidney International Reports|September 14, 2023
Children with Steroid Dependent Nephrotic Syndrome: Rituximab or Tacrolimus? It's All in the TimingMd Abdul Qader, Marina Vivarelli
Lancet (London, England)|January 30, 2026
TRPC6 inhibition: podocyte-targeted treatment for focal segmental glomerulosclerosis?Marina Vivarelli, Priya S Verghese
Pageof 15

Showing results (1-10 of 141) with videos related to

Sort By:
Pageof 15
Kidney International|July 23, 2022
What to do when a child with nephrotic syndrome has a cold? Learning from RCTsMarina Vivarelli, Elisabeth Hodson
Journal of Clinical Medicine|June 26, 2025
Advances in Complement Inhibitory Strategies for the Treatment of Glomerular Disease: A Rapidly Evolving FieldEster Conversano, Marina Vivarelli
Kidney International|November 25, 2019
A new mouse model of anti-GBM disease sheds light on maternal transfer of alloantibodies in glomerular diseaseMarina Vivarelli, Francesco Emma
Kidney International|January 5, 2019
Levamisole for children with nephrotic syndrome: new evidence for the use of an "old" drugMarina Vivarelli, Francesco Emma
Clinical Journal of the American Society of Nephrology : CJASN|November 7, 2022
How I Treat Steroid-Sensitive Nephrotic Syndrome in ChildrenMarina Vivarelli, Francesco Emma
Kidney International|July 1, 2025
Rituximab as first-line steroid-sparing agent in pediatric nephrotic syndrome: too early?Marina Vivarelli, Manuela Colucci
Seminars in Thrombosis and Hemostasis|May 7, 2014
Treatment of C3 glomerulopathy with complement blockersMarina Vivarelli, Francesco Emma
Kidney International|February 22, 2024
Anti-nephrin antibodies in recurrence of focal segmental glomerulosclerosis: closer to discovering the Holy Grail?Marina Vivarelli, Manuela Colucci
Kidney International Reports|September 14, 2023
Children with Steroid Dependent Nephrotic Syndrome: Rituximab or Tacrolimus? It's All in the TimingMd Abdul Qader, Marina Vivarelli
Lancet (London, England)|January 30, 2026
TRPC6 inhibition: podocyte-targeted treatment for focal segmental glomerulosclerosis?Marina Vivarelli, Priya S Verghese
Pageof 15